The cardiovascular-oncology theme in ICAMS, initiated in 2018, focuses on the effects of cancer and its treatment upon cardiovascular disease. Modern anticancer drugs improve cancer survival. However, this is associated with cardiovascular toxicities, the mechanisms of which remain largely unknown.Our mission is to address this gap.
Our pre-clinical studies provide cellular mechanistic insights into cancer therapy-related cardiovascular toxicity, while our clinical research aims to inform better prediction, prevention and treatment of potential or established cancer therapy-related cardiovascular toxicity . We aim to minimise the competing risks of cardiovascular disease in patients with cancer. This theme is truly at the interface between cardiovascular medicine and cancer – at the research and clinical levels.